Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options - ScienceDirect
IJMS, Free Full-Text
EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer, BMC Cancer
Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer
Super-enhancers complexes zoom in transcription in cancer, Journal of Experimental & Clinical Cancer Research
Cancers, Free Full-Text
Cancers, Free Full-Text
Frontiers Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers - Creative Proteomics